Arrowstreet Capital’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-286,039
| Closed | -$1.87M | – | 2286 |
|
|
2020
Q4 | $1.87M | Buy |
286,039
+175,693
| +159% | +$1.15M | ﹤0.01% | 1623 |
|
|
2020
Q3 | $734K | Buy |
110,346
+27,394
| +33% | +$182K | ﹤0.01% | 1903 |
|
|
2020
Q2 | $691K | Buy |
+82,952
| New | +$691K | ﹤0.01% | 1891 |
|
|
2018
Q4 | – | Sell |
-163,887
| Closed | -$3.03M | – | 1363 |
|
|
2018
Q3 | $3.03M | Buy |
163,887
+87,796
| +115% | +$1.62M | 0.01% | 615 |
|
|
2018
Q2 | $1.74M | Buy |
76,091
+50,268
| +195% | +$1.15M | ﹤0.01% | 707 |
|
|
2018
Q1 | $735K | Buy |
+25,823
| New | +$735K | ﹤0.01% | 912 |
|